These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 29462053)

  • 21. Four-factor prothrombin complex concentrate for life-threatening bleeds or emergent surgery: A retrospective evaluation.
    Sin JH; Berger K; Lesch CA
    J Crit Care; 2016 Dec; 36():166-172. PubMed ID: 27546767
    [TBL] [Abstract][Full Text] [Related]  

  • 22. French clinical practice guidelines on the management of patients on vitamin K antagonists in at-risk situations (overdose, risk of bleeding, and active bleeding).
    Pernod G; Godiér A; Gozalo C; Tremey B; Sié P;
    Thromb Res; 2010 Sep; 126(3):e167-74. PubMed ID: 20630568
    [TBL] [Abstract][Full Text] [Related]  

  • 23. INR and vitamin K-dependent factor levels after vitamin K antagonist reversal with 4F-PCC or plasma.
    Hood C; Goldstein JN; Milling TJ; Refaai MA; Bajcic P; Goldstein B; Sarode R
    Blood Adv; 2023 May; 7(10):2206-2213. PubMed ID: 36574241
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vitamin K for reversal of excessive vitamin K antagonist anticoagulation: a systematic review and meta-analysis.
    Khatib R; Ludwikowska M; Witt DM; Ansell J; Clark NP; Holbrook A; Wiercioch W; Schünemann H; Nieuwlaat R
    Blood Adv; 2019 Mar; 3(5):789-796. PubMed ID: 30850385
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Management of major bleeding complications and emergency surgery in patients on long-term treatment with direct oral anticoagulants, thrombin or factor-Xa inhibitors: proposals of the working group on perioperative haemostasis (GIHP) - March 2013.
    Pernod G; Albaladejo P; Godier A; Samama CM; Susen S; Gruel Y; Blais N; Fontana P; Cohen A; Llau JV; Rosencher N; Schved JF; de Maistre E; Samama MM; Mismetti P; Sié P;
    Arch Cardiovasc Dis; 2013; 106(6-7):382-93. PubMed ID: 23810130
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Emergency reversal of anticoagulation with vitamin K antagonists with 3-factor prothrombin complex concentrates in patients with major bleeding.
    Imberti D; Magnacavallo A; Dentali F; Condoleo E; Gallerani M; Benedetti R; Ageno W
    J Thromb Thrombolysis; 2013 Jul; 36(1):102-8. PubMed ID: 23054464
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [What is the current use of vitamin K antagonists in the elderly?].
    Vidal JS; Hanon O
    Geriatr Psychol Neuropsychiatr Vieil; 2013 Dec; 11(1 Suppl):17-22. PubMed ID: 24463060
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Avoiding emergency situations under anticoagulant therapy with vitamin K antagonists].
    Dempfle CE; Borggrefe M
    Internist (Berl); 2005 Sep; 46(9):1006-10, 1012-3. PubMed ID: 16082525
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The interaction between anticoagulant therapy with vitamin K-antagonists and treatment with antibiotics: a practical recommendation].
    Zelis M; Zweegman S; van der Meer FJ; Kramer MH; Smulders YM
    Ned Tijdschr Geneeskd; 2008 May; 152(18):1042-6. PubMed ID: 18547025
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Quality control of oral anticoagulation with vitamin K antagonists in primary care patients in Poland: a multi-centre study.
    Sawicka-Powierza J; Buczkowski K; Chlabicz S; Gugnowski Z; Powierza K; Ołtarzewska AM
    Kardiol Pol; 2018; 76(4):764-769. PubMed ID: 29313558
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A systematic review of prothrombin complex concentrate dosing strategies to reverse vitamin K antagonist therapy.
    Khorsand N; Kooistra HA; van Hest RM; Veeger NJ; Meijer K
    Thromb Res; 2015 Jan; 135(1):9-19. PubMed ID: 25480313
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Race against the clock: overcoming challenges in the management of anticoagulant-associated intracerebral hemorrhage.
    Le Roux P; Pollack CV; Milan M; Schaefer A
    J Neurosurg; 2014 Aug; 121 Suppl():1-20. PubMed ID: 25081496
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Meta-analysis to assess the quality of international normalized ratio control and associated outcomes in venous thromboembolism patients.
    Mearns ES; Kohn CG; Song JS; Hawthorne J; Meng J; White CM; Raut MK; Schein JR; Coleman CI
    Thromb Res; 2014 Aug; 134(2):310-9. PubMed ID: 24935672
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fixed Versus Variable Dosing of Prothrombin Complex Concentrate in Vitamin K Antagonist-Related Intracranial Hemorrhage: A Retrospective Analysis.
    Abdoellakhan RA; Miah IP; Khorsand N; Meijer K; Jellema K
    Neurocrit Care; 2017 Feb; 26(1):64-69. PubMed ID: 27052728
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reversal of the International Normalized Ratio with recombinant activated factor VII in central nervous system bleeding during warfarin thromboprophylaxis: clinical and biochemical aspects.
    Sørensen B; Johansen P; Nielsen GL; Sørensen JC; Ingerslev J
    Blood Coagul Fibrinolysis; 2003 Jul; 14(5):469-77. PubMed ID: 12851533
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-term quality of VKA treatment and clinical outcome after extreme overanticoagulation in 14,777 AF and VTE patients.
    Kooistra HA; Veeger NJ; Khorsand N; Kluin-Nelemans HC; Meijer K; Piersma-Wichers M
    Thromb Haemost; 2015 Apr; 113(4):881-90. PubMed ID: 25518854
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Therapy education for patients receiving oral anti-coagulants vitamin K antagonists].
    Satger B; Blaise S; Fontaine M; Yver J; Allenet B; Baudrant M; Pernod G; Bosson JL
    Presse Med; 2009 Dec; 38(12):1780-7. PubMed ID: 19815369
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An update of consensus guidelines for warfarin reversal.
    Tran HA; Chunilal SD; Harper PL; Tran H; Wood EM; Gallus AS;
    Med J Aust; 2013 Mar; 198(4):198-9. PubMed ID: 23451962
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Management of vitamin K antagonists in the elderly].
    Belleville T; Pautas É; Gaussem P; Siguret V
    Ann Biol Clin (Paris); 2014; 72(2):185-92. PubMed ID: 24736138
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Nontherapeutic international normalized ratio results in hospital emergency patients on vitamin K antagonists: prevalence and associated factors].
    López Altimiras X; Gené Tous E; De Giorgi A; Gadea Polo A; Martín Horcajo R; Jiménez Hernández S
    Emergencias; 2017 Abr; 29(2):93-98. PubMed ID: 28825250
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.